"L'équipe de professionnels de notre établissement de santé assure la prise en charge des urgences et de consultations en médecine pour vous apporter des soins de qualité.Pour plus d'informations et services, consultez notre site internet."

During the past decade, Centre Hospitalier du pays d'Aix conducted 44 clinical trials. In the 10-year time frame, 44 clinical trials started and 2 clinical trials were completed, i.e. on average, 4.5% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 2 clinical trials were completed. i.e. 8.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Hospitalier du pays d'Aix" #1 sponsor was "Intergroupe Francophone de Cancerologie Thoracique" with 14 trials, followed by "University Hospital, Toulouse" with 4 trials sponsored, "Boston Scientific Corporation" with 3 trials sponsored, "Federation Francophone de Cancerologie Digestive" with 3 trials sponsored and "Hospices Civils de Lyon" with 3 trials sponsored. Other sponsors include 56 different institutions and companies that sponsored additional 50 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier du pays d'Aix" #1 collaborator was "Groupe Francais De Pneumo-Cancerologie" with 4 trials as a collaborator, "Ministry of Health, France" with 4 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Centre Hospitalier du Pays d'Aix" with 2 trials as a collaborator and "Federation Francophone de Cancerologie Digestive" with 2 trials as a collaborator. Other collaborators include 85 different institutions and companies that were collaborators in the rest 90 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier du pays d'Aix" are "Non-small Cell Lung Cancer" (5 trials), "Parkinson's Disease" (5 trials), "Carcinoma, Non-Small-Cell Lung" (4 trials), "Heart Failure" (3 trials) and "ALK Gene Rearrangement Positive" (2 trials). Many other conditions were trialed in "Centre Hospitalier du pays d'Aix" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier du pays d'Aix" are "Drug" (44 trials), "Device" (15 trials), "Other" (12 trials), "Procedure" (6 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Gemcitabine" (4 trials), "Pemetrexed" (4 trials), "Bevacizumab" (3 trials), "Chemotherapy" (3 trials) and "placebo" (3 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier du pays d'Aix" are 85 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Centre Hospitalier du pays d'Aix". 1 are not yet recruiting, 17 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 52 completed trials in Centre Hospitalier du pays d'Aix, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier du pays d'Aix, 0 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 14 trials that are defined as “Not Applicable".

Centre Hospitalier du pays d'Aix has several departments that took part in Clinical trials: "C.H. Du Pays D'aix En Provence Service du Dr Blanc" - 4 trials, "Ch Du Pays D Aix; Pneumologie" - 2 trials, "Service de Cardiologie - Centre Hospitalier du Pays d'Aix" - 2 trials, "Service des maladies infectieuses, Centre Hospitalier du Pays d'Aix" - 2 trials